1Kukko M, Kimpimaki T, Kupila A, et al. Sisns of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the type 1 diabetes prediction and Prevention Study [ J ]. Diabetolosia,2003,46( 1 ) :65 -70.
2Kelly MA, Rayner ML, Mijovic CH, et al. Molecular aspects of type 1 diabetes [J]. Mol Pathol, 2003,56(1) :1 -10.
3Guja C, Marshall S, Welsh K, et al.The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population [ J ]. J Cell Mol Med, 2002,6( 1 ) :75 -81.
4Varela CR, Ellis R, Sgarbi G, et al.Characterization of the T-cell response to coxsackie B4: evidence that effector memory cells predominate in patients with type 1 diabetes [ J ]. Diabetes,2002,51:1745 - 1753.
5Roep BO. The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure [ J ], Diabetologia, 2003,46:305 - 321.
6Viglietta V, Kent SC,Orban T, et al.GAD65 - reactive T cells are activated in patients with autoimmune type 1 a diabetes[ J ]. J Clin Invest,2002,109 (7):869 - 870.
7Fujihira K,Nagata M,Moriyama H, et al. Supression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice [ J ]. Diabetes, 2000,49:1998 - 2006.
8Matsuki N, Stanic AK, Embers ME, et al. Genetic dissection of alpha 14J alpha 18 natural T cell number and function in autoimmune-prone mice [ J ]. J Immunol, 2003, 170 ( 11 ): 5429 -5437.
9Savinov AY, Tcherepanov A, Green FA, et al. Contribution of fas to diabetes development[ J]. Proc Natl Acad SciU S A, 2003,100(2): 628-632.
10Balasa B, Gunst KV, Jung N, et al.Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of fas,pefforin, TNF receptor-l, and TNF receptor-2 molecules[ J]. J Immunol,2000,165:2841- 2849.
